| Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial JP O’Reardon, HB Solvason, PG Janicak, S Sampson, KE Isenberg, ... Biological psychiatry 62 (11), 1208-1216, 2007 | 1944 | 2007 |
| Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome MA Demitrack, JK Dale, SE Straus, L Laue, SJ Listwak, MJP Kruesi, ... The Journal of Clinical Endocrinology & Metabolism 73 (6), 1224-1234, 1991 | 1036 | 1991 |
| Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease MP HEYES, K Saito, JS Crowley, LE Davis, MA Demitrack, M Der, ... Brain 115 (5), 1249-1273, 1992 | 780 | 1992 |
| Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial MJ Detke, Y Lu, DJ Goldstein, JR Hayes, MA Demitrack Journal of Clinical Psychiatry 63 (4), 308-315, 2002 | 644 | 2002 |
| Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial DJ Goldstein, C Mallinckrodt, Y Lu, MA Demitrack Journal of Clinical Psychiatry 63 (3), 225-231, 2002 | 457 | 2002 |
| Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine DJ Goldstein, Y Lu, MJ Detke, C Wiltse, C Mallinckrodt, MA Demitrack Journal of clinical psychopharmacology 24 (4), 389-399, 2004 | 427 | 2004 |
| Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression MJ Detke, Y Lu, DJ Goldstein, RK McNamara, MA Demitrack Journal of psychiatric research 36 (6), 383-390, 2002 | 423 | 2002 |
| Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice LL Carpenter, PG Janicak, ST Aaronson, T Boyadjis, DG Brock, IA Cook, ... Depression and anxiety 29 (7), 587-596, 2012 | 416 | 2012 |
| Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement A Drewnowski, DD Krahn, MA Demitrack, K Nairn, BA Gosnell Physiology & behavior 51 (2), 371-379, 1992 | 402 | 1992 |
| Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo-and paroxetine-controlled trial MJ Detke, CG Wiltse, CH Mallinckrodt, RK McNamara, MA Demitrack, ... European Neuropsychopharmacology 14 (6), 457-470, 2004 | 399 | 2004 |
| Evidence for and pathophysiologic implications of hypothalamic‐pituitary‐adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome MA Demitrack, LJ Crofford Annals of the New York Academy of sciences 840 (1), 684-697, 1998 | 350 | 1998 |
| Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during … PG Janicak, JP O'Reardon, SM Sampson, MM Husain, SH Lisanby, ... Journal of Clinical Psychiatry 69 (2), 222-232, 2008 | 322 | 2008 |
| Relation of clinical variables to dissociative phenomena in eating disorders. MA Demitrack, FW Putnam, TD Brewerton, HA Brandt, PW Gold context 5, 7, 1990 | 320 | 1990 |
| Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome LJ Crofford, EA Young, NC Engleberg, A Korszun, CB Brucksch, ... Brain, behavior, and immunity 18 (4), 314-325, 2004 | 313 | 2004 |
| Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters A Drewnowski, DD Krahn, MA Demitrack, K Nairn, BA Gosnell The American journal of clinical nutrition 61 (6), 1206-1212, 1995 | 288 | 1995 |
| Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder M Altemus, T Pigott, KT Kalogeras, M Demitrack, B Dubbert, DL Murphy, ... Archives of General Psychiatry 49 (1), 9-20, 1992 | 278 | 1992 |
| Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial R McKenzie, A O'Fallon, J Dale, M Demitrack, G Sharma, M Deloria, ... Jama 280 (12), 1061-1066, 1998 | 275 | 1998 |
| The responsiveness of the Hamilton depression rating scale D Faries, J Herrera, J Rayamajhi, D DeBrota, M Demitrack, WZ Potter Journal of psychiatric research 34 (1), 3-10, 2000 | 274 | 2000 |
| Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs CB Nemeroff, R Entsuah, I Benattia, M Demitrack, DM Sloan, ME Thase Biological psychiatry 63 (4), 424-434, 2008 | 253 | 2008 |
| Effects of duloxetine on painful physical symptoms associated with depression DJ Goldstein, Y Lu, MJ Detke, J Hudson, S Iyengar, MA Demitrack Psychosomatics 45 (1), 17-28, 2004 | 243 | 2004 |
